CervoMed Inc. Goodwill and Intangible Asset Impairment
CervoMed Inc. (CRVO) reported Goodwill and Intangible Asset Impairment of $6.67 million for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GoodwillAndIntangibleAssetImpairment · last filed 2016-03-25
- CervoMed Inc. goodwill and intangible asset impairment for the quarter ending 2014-12-31 was $6.67M.
- CervoMed Inc. goodwill and intangible asset impairment for the quarter ending 2014-09-30 was $0.00.
- CervoMed Inc. goodwill and intangible asset impairment for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. goodwill and intangible asset impairment for the quarter ending 2013-09-30 was $0.00.
- CervoMed Inc. goodwill and intangible asset impairment for fiscal 2014 was $6.67M, a 244.61% increase from fiscal 2013.
- CervoMed Inc. goodwill and intangible asset impairment for fiscal 2013 was $1.94M, a 35.94% increase from fiscal 2012.
- CervoMed Inc. goodwill and intangible asset impairment for fiscal 2012 was $1.42M, a 23.44% decline from fiscal 2011.
- CervoMed Inc. goodwill and intangible asset impairment for fiscal 2011 was $1.86M.
| Period end | Goodwill and Intangible Asset Impairment 3 month | Goodwill and Intangible Asset Impairment 6 month | Goodwill and Intangible Asset Impairment 9 month | Goodwill and Intangible Asset Impairment 12 month |
|---|---|---|---|---|
| 2014-12-31 | $6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $6.67M derived: sum of 2 quarters · filed 2016-03-25 | $6.67M 10-K · filed 2016-03-25 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | ||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | $0.00 derived: sum of 2 quarters · filed 2015-04-03 | $1.94M derived: sum of 3 quarters · filed 2015-04-03 | $1.94M 10-K · filed 2015-04-03 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-19 | $1.94M derived: sum of 2 quarters · filed 2014-08-14 | $1.94M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $1.94M 10-Q · filed 2014-08-14 | $1.94M 10-Q · filed 2014-08-14 | ||
| 2012-12-31 | $1.23M derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $1.42M 10-K/A · filed 2014-04-23 | ||
| 2012-09-30 | $197.50K 10-Q · filed 2013-11-19 | |||
| 2012-06-30 | $197.50K 10-Q · filed 2013-11-19 | |||
| 2011-12-31 | $1.86M 10-K/A · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |